Specification Change for Alzabistat. Labeling Change for Alzabistat — critical change. Impacts 6 markets and 5 variations.

Change Number
CHG-2021-0068
Type
Specification Change
Product
Status
Overdue
Owner
Priya Sharma
Initiated
2022-03-04
Description

Labeling Change for Alzabistat — critical change

Impacted Markets (6)
JP — JapanBR — BrazilFR — FranceIT — ItalySA — Saudi ArabiaBE — Belgium
Impacted Modules
3.2.P.3
Linked Variations (5)
Variation #TypeApplicationStatusSubmittedApproved
TITCK-2024-0036-V336Type IBTITCK-2024-0036Approved2023-05-302024-01-24
SFDA-2023-0037-V337MajorSFDA-2023-0037Active2023-07-09—
SAHPRA-2022-0038-V338Type IBSAHPRA-2022-0038Submitted2023-12-29—
Roszdravnadzor-2021-0039-V339MajorRoszdravnadzor-2021-0039Approved2022-08-042024-07-04
MOH-IL-2020-0040-V340Type IAMOH-IL-2020-0040Draft——